País: Irlanda
Idioma: anglès
Font: HPRA (Health Products Regulatory Authority)
TRAMADOL HYDROCHLORIDE
HGH Regulatory Sciences Limited
TRAMADOL HYDROCHLORIDE
200 Milligram
Tablet Prolonged Release
Product subject to prescription which may not be renewed (A)
Withdrawn
2010-01-18
IRISH MEDICINES BOARD ACTS 1995 AND 2006 MEDICINAL PRODUCTS(CONTROL OF PLACING ON THE MARKET)REGULATIONS,2007 (S.I. NO.540 OF 2007) PA1498/001/002 Case No: 2051459 The Irish Medicines Board in exercise of the powers conferred on it by the above mentioned Regulations hereby grants to HGH REGULATORY SCIENCES LIMITED LEDDERHOSER WEG 38, D 55543 BAD KREUZNACH, GERMANY an authorisation, subject to the provisions of the said Regulations, in respect of the product TRADOREC XL 200MG PROLONGED-RELEASE TABLETS The particulars of which are set out in Part I and Part II of the attached Schedule. The authorisation is also subject to the general conditions as may be specified in the said Regulations as listed on the reverse of this document. This authorisation, unless previously revoked, shall continue in force from 07/08/2009 until 06/08/2014. Signed on behalf of the Irish Medicines Board this ________________ A person authorised in that behalf by the said Board. IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 10/08/2009_ _CRN 2051459_ _page number: 1_ PART II SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Tradorec XL 200mg prolonged-release tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION One prolonged-release tablet contains 200mg tramadol hydrochloride For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Prolonged-release tablet White to off white, plain, bevelled edge, round biconvex tablet 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment of moderate to severe pain. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION The dosage should be adjusted according to the severity of pain and the response of the individual patient. The prolonged-release tablets should be swall Llegiu el document complet